Moreover, it was reported that SOX2 confers resistance to ferroptosis through upregulation of SLC7A11 expression in lung cancer stem-like cells (CSLC) which implies that SOX2 could be a potential therapeutic target for cancer treatment (93). Here, SOX2 is linked to lung carcinoma.